Cargando…
Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review()
BACKGROUND: Vaccine adjuvants are compounds that significantly enhance/prolong the immune response to a co-administered antigen. The limitations of the use of aluminium salts that are unable to elicite cell responses against intracellular pathogens such as those causing malaria, tuberculosis, or AID...
Autor principal: | Lacaille-Dubois, Marie-Aleth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127804/ https://www.ncbi.nlm.nih.gov/pubmed/31182297 http://dx.doi.org/10.1016/j.phymed.2019.152905 |
Ejemplares similares
-
Trial watch: an update of clinical advances in photodynamic therapy and its immunoadjuvant properties for cancer treatment
por: Penetra, Mafalda, et al.
Publicado: (2023) -
Silica-based cationic bilayers as immunoadjuvants
por: Lincopan, Nilton, et al.
Publicado: (2009) -
Abstract QS21: Leadership In Plastic Surgery
por: Murphy, Carolyn P., et al.
Publicado: (2019) -
QS-21: A Potent Vaccine Adjuvant
por: Zhu, Daming, et al.
Publicado: (2015) -
Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis
por: Cao, Ruoqiong, et al.
Publicado: (2018)